Partnerselskabet Amalieklinikken 2021
CVR number: 32345662
Dronningens Tværgade 30, 1302 København K
info@amalieklinikken.dk
tel: 76500500
Income statement (kDKK)
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 22 914.20 | 19 370.10 | 22 638.42 | 27 311.83 | 15 201.95 |
Employee benefit expenses | -20 999.11 | -19 096.15 | -20 043.15 | -22 987.98 | -13 451.79 |
Total depreciation | - 860.19 | -1 011.45 | - 941.93 | - 986.83 | -29 657.59 |
EBIT | 1 054.90 | - 737.50 | 1 653.34 | 3 337.02 | 31 407.75 |
Other financial income | 7.24 | 4.90 | 16.57 | 591.95 | |
Other financial expenses | - 104.86 | -77.64 | -80.94 | - 105.15 | -86.52 |
Pre-tax profit | 950.04 | - 807.89 | 1 577.30 | 3 248.44 | 31 913.17 |
Net earnings | 950.04 | - 807.89 | 1 577.30 | 3 248.44 | 31 913.17 |
Assets (kDKK)
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Goodwill | 857.14 | 571.43 | 285.71 | ||
Intangible assets total | 857.14 | 571.43 | 285.71 | ||
Buildings | 2 002.43 | 1 880.77 | 1 557.89 | 1 229.02 | |
Machinery and equipment | 1 676.94 | 1 427.93 | 1 268.64 | 896.40 | |
Tangible assets total | 3 679.37 | 3 308.70 | 2 826.53 | 2 125.42 | |
Other receivables | 526.46 | 535.59 | 541.83 | 547.45 | |
Investments total | 526.46 | 535.59 | 541.83 | 547.45 | |
Long term receivables total | |||||
Raw materials and consumables | 370.21 | 458.07 | 489.54 | 943.14 | |
Inventories total | 370.21 | 458.07 | 489.54 | 943.14 | |
Current trade debtors | 24.50 | ||||
Prepayments and accrued income | 15.78 | 15.02 | 48.59 | 17.04 | |
Current other receivables | 159.97 | 187.53 | 54.88 | 562.20 | 39 988.57 |
Short term receivables total | 200.25 | 202.55 | 103.47 | 579.25 | 39 988.57 |
Cash and bank deposits | 935.11 | 602.00 | 3 233.30 | 6 527.02 | |
Cash and cash equivalents | 935.11 | 602.00 | 3 233.30 | 6 527.02 | |
Balance sheet total (assets) | 6 568.55 | 5 678.34 | 7 480.38 | 10 722.27 | 39 988.57 |
Equity and liabilities (kDKK)
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Share capital | 3 101.00 | 3 101.00 | 3 101.00 | 3 101.00 | 3 101.00 |
Shares repurchased | 1 900.00 | 25 000.00 | |||
Retained earnings | 212.29 | 1 162.33 | -1 545.57 | 31.74 | -28 719.82 |
Profit of the financial year | 950.04 | - 807.89 | 1 577.30 | 3 248.44 | 31 913.17 |
Shareholders equity total | 4 263.33 | 3 455.43 | 5 032.74 | 6 381.18 | 31 294.36 |
Non-current deferred tax liabilities | 208.06 | 678.50 | |||
Non-current liabilities total | 208.06 | 678.50 | |||
Current loans from credit institutions | 17.60 | 4.29 | |||
Advances received | 42.00 | 119.00 | 136.00 | 49.00 | |
Current trade creditors | 392.37 | 382.63 | 437.80 | 199.30 | |
Current owed to participating | 8.81 | 8.81 | 4.32 | 4.32 | 7 004.32 |
Other non-interest bearing current liabilities | 1 844.44 | 1 712.46 | 1 661.47 | 3 405.69 | 1 689.90 |
Current liabilities total | 2 305.22 | 2 222.90 | 2 239.58 | 3 662.60 | 8 694.22 |
Balance sheet total (liabilities) | 6 568.55 | 5 678.34 | 7 480.38 | 10 722.27 | 39 988.57 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.